We studied the clinicopathological characteristics of OC in the low- and high-risk groups, including age, stage, grade, new neoplasm event type, BRCA1 mutation status, BRCA2 mutation status, 19q13.2 CNV status, and 19q13.42 CNV status. This evidence concerns the gene BRCA1 and neoplasm.